Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
FDA Orange Book
0
Canada
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Controlled & Modified Release
Fillers, Diluents & Binders
Film Formers & Plasticizers
Coating Systems & Additives
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
72
PharmaCompass offers a list of Human Chorionic Gonadotropin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Human Chorionic Gonadotropin manufacturer or Human Chorionic Gonadotropin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Human Chorionic Gonadotropin manufacturer or Human Chorionic Gonadotropin supplier.
PharmaCompass also assists you with knowing the Human Chorionic Gonadotropin API Price utilized in the formulation of products. Human Chorionic Gonadotropin API Price is not always fixed or binding as the Human Chorionic Gonadotropin Price is obtained through a variety of data sources. The Human Chorionic Gonadotropin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A beta-Subunit hcg (123-145) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of beta-Subunit hcg (123-145), including repackagers and relabelers. The FDA regulates beta-Subunit hcg (123-145) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. beta-Subunit hcg (123-145) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of beta-Subunit hcg (123-145) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A beta-Subunit hcg (123-145) supplier is an individual or a company that provides beta-Subunit hcg (123-145) active pharmaceutical ingredient (API) or beta-Subunit hcg (123-145) finished formulations upon request. The beta-Subunit hcg (123-145) suppliers may include beta-Subunit hcg (123-145) API manufacturers, exporters, distributors and traders.
click here to find a list of beta-Subunit hcg (123-145) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A beta-Subunit hcg (123-145) DMF (Drug Master File) is a document detailing the whole manufacturing process of beta-Subunit hcg (123-145) active pharmaceutical ingredient (API) in detail. Different forms of beta-Subunit hcg (123-145) DMFs exist exist since differing nations have different regulations, such as beta-Subunit hcg (123-145) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A beta-Subunit hcg (123-145) DMF submitted to regulatory agencies in the US is known as a USDMF. beta-Subunit hcg (123-145) USDMF includes data on beta-Subunit hcg (123-145)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The beta-Subunit hcg (123-145) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of beta-Subunit hcg (123-145) suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The beta-Subunit hcg (123-145) Drug Master File in Japan (beta-Subunit hcg (123-145) JDMF) empowers beta-Subunit hcg (123-145) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the beta-Subunit hcg (123-145) JDMF during the approval evaluation for pharmaceutical products. At the time of beta-Subunit hcg (123-145) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of beta-Subunit hcg (123-145) suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing beta-Subunit hcg (123-145) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for beta-Subunit hcg (123-145) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture beta-Subunit hcg (123-145) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain beta-Subunit hcg (123-145) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a beta-Subunit hcg (123-145) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of beta-Subunit hcg (123-145) suppliers with NDC on PharmaCompass.
beta-Subunit hcg (123-145) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of beta-Subunit hcg (123-145) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right beta-Subunit hcg (123-145) GMP manufacturer or beta-Subunit hcg (123-145) GMP API supplier for your needs.
A beta-Subunit hcg (123-145) CoA (Certificate of Analysis) is a formal document that attests to beta-Subunit hcg (123-145)'s compliance with beta-Subunit hcg (123-145) specifications and serves as a tool for batch-level quality control.
beta-Subunit hcg (123-145) CoA mostly includes findings from lab analyses of a specific batch. For each beta-Subunit hcg (123-145) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
beta-Subunit hcg (123-145) may be tested according to a variety of international standards, such as European Pharmacopoeia (beta-Subunit hcg (123-145) EP), beta-Subunit hcg (123-145) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (beta-Subunit hcg (123-145) USP).
